Royalty Pharma EVP Marshall Urist sells 4,126 shares for $238,812.88
RPRX•Marshall Urist sold 4,126 Royalty Pharma Class A ordinary shares on Sept. 28, 2026, for $57.88 each, totaling $238,812.88.
1. Share sale
Marshall Urist, Royalty Pharma’s EVP of Research & Investments, sold 4,126 Class A ordinary shares on Sept. 28, 2026, at $57.88 per share. His direct holdings fell to 4,126 shares; indirect holdings include 19,020 shares held by an IRA.
